About this trial
Some of the patients affected by Out-of-hospital cardiac arrest (OHCA) with ventricular fibrillation (VF)/ventricular tachycardia (VT) do not respond to initial defibrillation. The survival decreases with number of defibrillations required to terminate VF/VT. In 2022, one prospective cluster randomized trial showed increased survival among (OHCA) patients in refractory VF using Double Sequential Defibrillation (DSD). If DSD can increase survival among all patients in VF that dont respond to one defibrillation, i.e. before it has become refractory is not known.
The aim of this trial is to assess survival with a double defibrillation strategy initiated as soon as possible among patients with Out of Hospital Cardiac Arrest with initial shockable rhythm and at least one failed standard defibrillation, compared with continued resuscitation using standard defibrillation.
Eligibility criteria
Qualifiers
OHCA patients with VT/VF at first rhythm analysis and at least one defibrillation performed in standard (A-L) position
Disqualifiers
Age < 18 years
Obvious pregnancy
Known preexisting Do Not Attempt Resuscitation order
Trial design
Treatments tested in this trial
- Double sequential defibirllation
- Standard defibrillation
Treatment groups
Sponsors and collaborators
Gabriel Riva
Lead sponsor
Karolinska Institutet
Sponsor institution
Swedish Heart Lung Foundation
Collaborator
Region Stockholm
Collaborator
Vastra Gotaland Region
Collaborator
Region Halland
Collaborator
Laerdal Foundation
Collaborator